202 related articles for article (PubMed ID: 28824609)
1. Protein-Protein Interaction between Surfactant Protein D and DC-SIGN
Dodagatta-Marri E; Mitchell DA; Pandit H; Sonawani A; Murugaiah V; Idicula-Thomas S; Nal B; Al-Mozaini MM; Kaur A; Madan T; Kishore U
Front Immunol; 2017; 8():834. PubMed ID: 28824609
[TBL] [Abstract][Full Text] [Related]
2. Human surfactant protein D facilitates SARS-CoV-2 pseudotype binding and entry in DC-SIGN expressing cells, and downregulates spike protein induced inflammation.
Beirag N; Kumar C; Madan T; Shamji MH; Bulla R; Mitchell D; Murugaiah V; Neto MM; Temperton N; Idicula-Thomas S; Varghese PM; Kishore U
Front Immunol; 2022; 13():960733. PubMed ID: 35967323
[TBL] [Abstract][Full Text] [Related]
3. Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells.
Madsen J; Gaiha GD; Palaniyar N; Dong T; Mitchell DA; Clark HW
PLoS One; 2013; 8(3):e59047. PubMed ID: 23527085
[TBL] [Abstract][Full Text] [Related]
4. Surfactant protein D inhibits mite-induced alveolar macrophage and dendritic cell activations through TLR signalling and DC-SIGN expression.
Liu CF; Rivere M; Huang HJ; Puzo G; Wang JY
Clin Exp Allergy; 2010 Jan; 40(1):111-22. PubMed ID: 20205699
[TBL] [Abstract][Full Text] [Related]
5. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
[TBL] [Abstract][Full Text] [Related]
6. AM3 modulates dendritic cell pathogen recognition capabilities by targeting DC-SIGN.
Serrano-Gómez D; Martínez-Nuñez RT; Sierra-Filardi E; Izquierdo N; Colmenares M; Pla J; Rivas L; Martinez-Picado J; Jimenez-Barbero J; Alonso-Lebrero JL; González S; Corbí AL
Antimicrob Agents Chemother; 2007 Jul; 51(7):2313-23. PubMed ID: 17452477
[TBL] [Abstract][Full Text] [Related]
7. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
[TBL] [Abstract][Full Text] [Related]
8. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigen-capturing rather than an adhesion receptor.
Snyder GA; Ford J; Torabi-Parizi P; Arthos JA; Schuck P; Colonna M; Sun PD
J Virol; 2005 Apr; 79(8):4589-98. PubMed ID: 15795245
[TBL] [Abstract][Full Text] [Related]
9. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
11. DC-SIGN points the way to a novel mechanism for HIV-1 transmission.
Masso M
MedGenMed; 2003 May; 5(2):2. PubMed ID: 14603101
[TBL] [Abstract][Full Text] [Related]
12. Bile salt-stimulated lipase from human milk binds DC-SIGN and inhibits human immunodeficiency virus type 1 transfer to CD4+ T cells.
Naarding MA; Dirac AM; Ludwig IS; Speijer D; Lindquist S; Vestman EL; Stax MJ; Geijtenbeek TB; Pollakis G; Hernell O; Paxton WA
Antimicrob Agents Chemother; 2006 Oct; 50(10):3367-74. PubMed ID: 17005819
[TBL] [Abstract][Full Text] [Related]
13. Complement Protein C1q Interacts with DC-SIGN
Pednekar L; Pandit H; Paudyal B; Kaur A; Al-Mozaini MA; Kouser L; Ghebrehiwet B; Mitchell DA; Madan T; Kishore U
Front Immunol; 2016; 7():600. PubMed ID: 28066413
[TBL] [Abstract][Full Text] [Related]
14. Surfactant Protein D Reverses the Gene Signature of Transepithelial HIV-1 Passage and Restricts the Viral Transfer Across the Vaginal Barrier.
Pandit H; Kale K; Yamamoto H; Thakur G; Rokade S; Chakraborty P; Vasudevan M; Kishore U; Madan T; Fichorova RN
Front Immunol; 2019; 10():264. PubMed ID: 30984160
[TBL] [Abstract][Full Text] [Related]
15. Monovalent mannose-based DC-SIGN antagonists: targeting the hydrophobic groove of the receptor.
Tomašić T; Hajšek D; Švajger U; Luzar J; Obermajer N; Petit-Haertlein I; Fieschi F; Anderluh M
Eur J Med Chem; 2014 Mar; 75():308-26. PubMed ID: 24556146
[TBL] [Abstract][Full Text] [Related]
16. Surfactant protein A binds to HIV and inhibits direct infection of CD4+ cells, but enhances dendritic cell-mediated viral transfer.
Gaiha GD; Dong T; Palaniyar N; Mitchell DA; Reid KB; Clark HW
J Immunol; 2008 Jul; 181(1):601-9. PubMed ID: 18566427
[TBL] [Abstract][Full Text] [Related]
17. Lewis X component in human milk binds DC-SIGN and inhibits HIV-1 transfer to CD4+ T lymphocytes.
Naarding MA; Ludwig IS; Groot F; Berkhout B; Geijtenbeek TB; Pollakis G; Paxton WA
J Clin Invest; 2005 Nov; 115(11):3256-64. PubMed ID: 16239964
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides.
Arnáiz B; Martínez-Ávila O; Falcon-Perez JM; Penadés S
Bioconjug Chem; 2012 Apr; 23(4):814-25. PubMed ID: 22433013
[TBL] [Abstract][Full Text] [Related]
19. DC-SIGN plays a stronger role than DCIR in mediating HIV-1 capture and transfer.
Jin W; Li C; Du T; Hu K; Huang X; Hu Q
Virology; 2014 Jun; 458-459():83-92. PubMed ID: 24928041
[TBL] [Abstract][Full Text] [Related]
20. DCIR interacts with ligands from both endogenous and pathogenic origin.
Bloem K; Vuist IM; van den Berk M; Klaver EJ; van Die I; Knippels LM; Garssen J; García-Vallejo JJ; van Vliet SJ; van Kooyk Y
Immunol Lett; 2014; 158(1-2):33-41. PubMed ID: 24239607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
